Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0000950103-24-013644
Filing Date
2024-09-17
Accepted
2024-09-17 07:02:19
Documents
3
Period of Report
2024-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 6K dp218055_6k.htm 6-K 12224
2 EXHIBIT 99.1 dp218055_ex9901.htm EX-99.1 21479
3 GRAPHIC image_001.jpg GRAPHIC 53415
  Complete submission text file 0000950103-24-013644.txt   108339
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Filer) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37891 | Film No.: 241302564
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)